Wednesday, February 11

Healthcare

Entero Therapeutics receives Nasdaq notification regarding delayed form 10-Q

08/26/20241 Min Read

10Q delayed Entero form Nasdaq notification receives Therapeutics

Previous ArticleARCA biopharma approves 1-for-12 reverse stock split

Next Article Ocean Biomedical receives non-compliance notice from Nasdaq (NASDAQ:OCEA)